Oxford BioDynamics ( (GB:OBD) ) just unveiled an announcement.
Oxford BioDynamics PLC has announced a change in its major holdings, with Spreadex LTD acquiring or disposing of financial instruments, resulting in a shift in voting rights. The transaction has led to a decrease in the total percentage of voting rights held by Spreadex LTD, which could impact the company’s influence on corporate decisions and its strategic positioning within the industry.
More about Oxford BioDynamics
Oxford BioDynamics PLC operates in the biotechnology industry, focusing on the development and commercialization of precision medicine technologies. The company is known for its EpiSwitch platform, which is used for biomarker discovery and development, targeting various therapeutic areas.
YTD Price Performance: -65.00%
Average Trading Volume: 21,108,350
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £9.3M
See more insights into OBD stock on TipRanks’ Stock Analysis page.